[[[(2R,3R,4R,5R)-5-(6-benzamidopurin-9-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-methoxyoxolan-3-yl]oxy-hydroxyphosphanyl]amino]-(2-cyanoethyl)-di(propan-2-yl)azanium

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: [[[(2R,3R,4R,5R)-5-(6-benzamidopurin-9-yl)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-methoxyoxolan-3-yl]oxy-hydroxyphosphanyl]amino]-(2-cyanoethyl)-di(propan-2-yl)azanium
• 化学式: C48H56N8O8P+
• 分子量: 904.0
• InChiKey: CNEAVZVBUFJXMD-KLJQIIHSSA-O

计算性质

• 辛醇/水分配系数(LogP)：
  6
• 重原子数：
  65
• 可旋转键数：
  20
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  184
• 氢给体数：
  3
• 氢受体数：
  13

文献信息

• Small molecule conjugates for intracellular delivery of nucleic acids
  申请人：Hoffmann-La Roche Inc.

  公开号：US20140135380A1

  公开（公告）日：2014-05-15

  The invention provides use of novel compounds for delivery of nucleic acids, and conjugates of these compounds with nucleic acids. Further novel design criteria for chemically stabilized siRNA particular useful when covalently attached to said compounds and co-administered with a delivery polymer to achieve mRNA knock down in vivo are disclosed therein.

  本发明提供了一种使用新化合物进行核酸传递的方法，并提供了这些化合物与核酸的结合物。此外，还揭示了一种新的设计标准，用于化学稳定的siRNA，当与该化合物共价结合并与传递聚合物共同给予时，可在体内实现mRNA靶向下调。
• CHIMERIC POLYNUCLEOTIDES
  申请人：ModernaTX, Inc.

  公开号：EP3169693B1

  公开（公告）日：2022-03-09
• POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION
  申请人：ModernaTX, Inc.

  公开号：EP3350333B1

  公开（公告）日：2021-10-27
• Compositions and Methods for Inhibition of Factor XII Gene Expression
  申请人：Arrowhead Pharmaceuticals, Inc.

  公开号：US20190382763A1

  公开（公告）日：2019-12-19

  RNA interference agents for inhibiting the expression of Factor XII (FXII) gene are described. Pharmaceutical compositions comprising one or more FXII RNAi agents together with one or more excipients capable of delivering the RNAi agent(s) to a liver cell in Vivo are also described. Delivery of the FXII RNAi agent(s) to liver cells in vivo provides for inhibition of FXII gene expression and treatment of angioedema, including hereditary angioedema (HAE) and venous thromboembolism (VTE), and diseases associated with angioedema.
• US9198947B2
  申请人：——

  公开号：US9198947B2

  公开（公告）日：2015-12-01